G

Galectin Therapeutics
D

GALT

1.49000
USD
0.03
(1.71%)
مغلق
حجم التداول
4,232
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
93,515,119
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Galectin Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.